These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33625694)

  • 1. Awareness and Knowledge Among Internal Medicine House-Staff for Dose Adjustment of Cardiovascular Drugs in Chronic Kidney Disease.
    D'Angelo K; Paul S; Ranjeeta F; Fogel J; Chikvashvili D; Rubinstein S
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):177-184. PubMed ID: 33625694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD.
    Surana S; Kumar N; Vasudeva A; Shaikh G; Jhaveri KD; Shah H; Malieckal D; Fogel J; Sidhu G; Rubinstein S
    BMC Nephrol; 2017 Jan; 18(1):26. PubMed ID: 28095816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness and Knowledge Among Internal Medicine Resident Trainees for Dose Adjustment of Analgesics and Neuropsychotropic Medications in CKD.
    Saad CY; Fogel J; Rubinstein S
    South Med J; 2018 Mar; 111(3):155-162. PubMed ID: 29505650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose adjustment of antidiabetic medications in chronic kidney disease.
    Snyder MS; Fogel J; Pyatigorskaya S; Rubinstein S
    Avicenna J Med; 2021; 11(1):33-39. PubMed ID: 33520787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception of indications for nephrology referral among internal medicine residents: a national online survey.
    Agrawal V; Ghosh AK; Barnes MA; McCullough PA
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):323-8. PubMed ID: 19218472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and management of chronic kidney disease complications by internal medicine residents: a national survey.
    Agrawal V; Agarwal M; Ghosh AK; Barnes MA; McCullough PA
    Am J Ther; 2011 May; 18(3):e40-7. PubMed ID: 19918169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial.
    Bangalore S; Abhaichand R; Mullasari A; Jain R; Chand RKP; Arambam P; Kaul U
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1075-1080. PubMed ID: 31036397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey.
    Agrawal V; Ghosh AK; Barnes MA; McCullough PA
    Am J Kidney Dis; 2008 Dec; 52(6):1061-9. PubMed ID: 18976845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet effects of aspirin in chronic kidney disease patients.
    Polzin A; Dannenberg L; Sansone R; Levkau B; Kelm M; Hohlfeld T; Zeus T
    J Thromb Haemost; 2016 Feb; 14(2):375-80. PubMed ID: 26644261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum sodium levels with all-cause and cardiovascular mortality in chronic kidney disease: Results from a prospective observational study.
    Chiu DY; Kalra PA; Sinha S; Green D
    Nephrology (Carlton); 2016 Jun; 21(6):476-82. PubMed ID: 26426983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
    Goicoechea M; de Vinuesa SG; Quiroga B; Verde E; Bernis C; Morales E; Fernández-Juárez G; de Sequera P; Verdalles U; Delgado R; Torres A; Arroyo D; Abad S; Ortiz A; Luño J
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):255-263. PubMed ID: 29943364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.
    Kopel T; Kaufman JS; Hamburg N; Sampalis JS; Vita JA; Dember LM
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1588-1594. PubMed ID: 28784655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.
    Sjöberg B; Qureshi AR; Heimbürger O; Stenvinkel P; Lind L; Larsson A; Bárány P; Ärnlöv J
    J Intern Med; 2016 Feb; 279(2):173-9. PubMed ID: 26355706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives.
    Satirapoj B; Supasyndh O; Mayteedol N; Punpanich D; Chaiprasert A; Nata N; Ruangkanchanasetr P; Kanjanakul I; Choovichian P
    Nephrology (Carlton); 2013 Mar; 18(3):229-34. PubMed ID: 23279639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light wine consumption is associated with a lower odd for cardiovascular disease in chronic kidney disease.
    Jespersen T; Kruse N; Mehta T; Kuwabara M; Noureddine L; Jalal D
    Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1133-1139. PubMed ID: 30143406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of arterial stiffness in nondiabetic chronic kidney disease patients.
    Mastanvalli B; Kumar KP; Madhav D; Venkata Pakki Reddy PL; Vali SM
    Saudi J Kidney Dis Transpl; 2017; 28(1):61-67. PubMed ID: 28098104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advance care planning in chronic kidney disease: A survey of current practice in Australia.
    Luckett T; Spencer L; Morton RL; Pollock CA; Lam L; Silvester W; Sellars M; Detering KM; Butow PN; Tong A; Clayton JM
    Nephrology (Carlton); 2017 Feb; 22(2):139-149. PubMed ID: 26860214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of kidney function-related dietary pattern, weight status, and cardiovascular risk factors with severity of impaired kidney function in middle-aged and older adults with chronic kidney disease: a cross-sectional population study.
    Kurniawan AL; Hsu CY; Rau HH; Lin LY; Chao JC
    Nutr J; 2019 Apr; 18(1):27. PubMed ID: 31010424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is renal hyperfiltration protective in chronic kidney disease-stage 1 pregnancies? A step forward unravelling the mystery of the effect of stage 1 chronic kidney disease on pregnancy outcomes.
    Piccoli GB; Attini R; Vigotti FN; Parisi S; Fassio F; Pagano A; Biolcati M; Giuffrida D; Rolfo A; Todros T
    Nephrology (Carlton); 2015 Mar; 20(3):201-8. PubMed ID: 25470206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.
    Bagai A; Lu D; Lucas J; Goyal A; Herzog CA; Wang TY; Goodman SG; Roe MT
    J Am Heart Assoc; 2018 Dec; 7(24):e010394. PubMed ID: 30514137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.